Cupertino, CA, United States of America

Kutub Mahmood

USPTO Granted Patents = 13 



Average Co-Inventor Count = 4.8

ph-index = 6

Forward Citations = 144(Granted Patents)


Location History:

  • Rockville, MD (US) (2011 - 2016)
  • Cupertino, CA (US) (2013 - 2020)
  • Gaithersburg, MD (US) (2017 - 2020)

Company Filing History:


Years Active: 2011-2020

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Innovations of Kutub Mahmood in Influenza Virus Research

Introduction

Kutub Mahmood is a prominent inventor based in Cupertino, CA, known for his significant contributions to the field of virology, particularly in the development of influenza virus-like particles (VLPs). With a total of 13 patents to his name, Mahmood has made strides in creating innovative solutions to combat influenza viruses.

Latest Patents

Mahmood's latest patents focus on functional influenza virus-like particles (VLPs). These inventions disclose and claim VLPs that express and/or contain seasonal influenza virus proteins, avian influenza virus proteins, and influenza virus proteins from viruses with pandemic potential. The inventions include vector constructs comprising these proteins, cells containing said constructs, formulations, and vaccines that utilize the VLPs. Additionally, the patents outline methods for producing and administering VLPs to vertebrates, aiming to induce substantial immunity to seasonal and avian influenza or alleviate at least one symptom thereof.

Career Highlights

Kutub Mahmood is currently associated with Novavax, Inc., where he continues to advance his research in the field of influenza. His work has been instrumental in developing vaccines that can potentially save lives during influenza outbreaks.

Collaborations

Mahmood has collaborated with notable colleagues such as Gale Smith and Peter M Pushko, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Kutub Mahmood's work in the development of influenza virus-like particles represents a significant advancement in vaccine technology. His contributions are vital in the ongoing fight against influenza and highlight the importance of innovation in public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…